The transcriptomic landscape of monosomy X (45,X) during early human fetal and placental development

Jenifer P. Suntharalingham,Ignacio del Valle,Federica Buonocore,Sinead M. McGlacken-Byrne,Tony Brooks,Olumide K. Ogunbiyi,Danielle Liptrot,Nathan Dunton,Gaganjit K Madhan,Kate Metcalfe,Lydia Nel,Abigail R. Marshall,Miho Ishida,Neil J. Sebire,Gudrun E. Moore,Berta Crespo,Nita Solanky,Gerard S. Conway,John C. Achermann
DOI: https://doi.org/10.1101/2024.03.01.582942
2024-03-04
Abstract:Monosomy X (45,X) is associated with Turner syndrome and pregnancy loss in humans, but the underlying mechanisms remain unclear. We therefore analyzed the transcriptomic landscape of clinically relevant human fetal 45,X tissues (including pancreas, liver, kidney, skin, placenta) with matched 46,XX and 46,XY control samples between 11-15 weeks post conception (n=78). Although most pseudoautosomal region 1 (PAR1) genes were lower in monosomy X tissues, we also found reduced expression of several key genes escaping X inactivation (e.g., and ), and potentially clinically important transcripts such as genes implicated in ascending aortic aneurysm. In contrast, expression of an autosomal, long non-coding RNA ( ) was seen in all 45,X tissues. In the placenta, lower expression of was demonstrated, likely contributing to immune dysregulation. Taken together, these findings provide novel insights into the biological consequences of a single X chromosome during early human development and potential insights in genetic mechanisms in Turner syndrome.
Genetics
What problem does this paper attempt to address?